Electrochemiluminescence Technology Research Articles

Enhanced electrochemiluminescence at microgel-functionalized beads

Bead-based assays are successfully combined with electrochemiluminescence (ECL) technology for detection of a wide range of biomarkers. Herein, we demonstrate a novel approach to enhance the ECL signal by decorating micrometric beads with [Ru(bpy)3]2+-grafted microgels (diameter ∼100 nm). Rapid and stable light emission was spatially resolved at the level of single functionalized beads. An enhancement of the ECL signal of microgel-labeled beads by 9-fold was observed in comparison to molecularly linked [Ru(bpy)3]2+ beads prepared by a sandwich immunoassay or an amide bond. Imaging the ECL signal at the single bead level shows that the size of the ECL-emitting layer is extended using the microgels. The reported method offers a great promise for the optimization of bead-based ECL detection and subsequent development of ECL microscopy.

High-bioactivity microfluidic immunosensing platform for electrochemiluminescence determination of CYFRA 21-1 with the introduction of Fe3O4@Cu@Cu2O.

Relying on the electrochemiluminescence (ECL) and microfluidic technology, an immunosensor chip with high bioactivity was designed for sensitive determination of cytokeratin 19 fragment 21-1 (CYFRA 21-1). The mesoporous nanomaterial Fe3O4@Cu@Cu2O as the co-reaction accelerator was used to catalyze the S2O82- to produce more SO4•- to achieve the amplification of theECL signal. In fact, the generating of SO4•- could not only be done with the aid of the reversible cycles of Fe2+ and Fe3+ and Cu+ and Cu2+, but could be achieved also through the catalase-like function of Fe3O4. What is more, it has also been proved that Fe3O4@Cu@Cu2O exhibited better catalytic performance than single Fe3O4, Cu2O, and Cu@Cu2O, which supported its application in this system. In addition, a portable microfluidic immunosensor chip for CYFRA 21-1-sensitive determination was assembled, which showed high selectivity, sensitivity, and strong universality in clinical cancer screening and diagnosis. It should be noted that HWRGWVC (HWR) was introduced as the antibody fixator to improve the incubation and binding efficiency of theantibody, which increased theECL intensity and improved the sensitivity of the immunosensor. This strategy provided a new idea for cancer identification and diagnosis in clinical medicine.

High-Efficiency CdSe Quantum Dots/Fe3O4@MoS2/S2O82- Electrochemiluminescence System Based on a Microfluidic Analysis Platform for the Sensitive Detection of Neuron-Specific Enolase.

In this work, based on electrochemiluminescence (ECL) technology and self-assembled portable disease detection chips, a bioactivity-maintained sensing platform was developed for the quantitative detection of neuron-specific enolase. First, we prepared Fe3O4@MoS2 nanocomposites as an efficient catalyst to accelerate the reduction of persulfate (S2O82-). Specifically, abundant sulfate radicals (SO4•-) were generated because of cyclic conversion between Fe2+ and Fe3+. Meanwhile, MoS2 nanoflowers with a high specific surface area could not only load more Fe3O4 but also solve its agglomeration problem, which greatly improved the catalytic efficiency. Moreover, a biosensor chip was constructed by standard lithography processes for disease detection, which had good sensitivity and portability. According to the above strategies, the developed portable sensing platform played the part of promoting the practical application of bioanalysis in early tumor screening and clinical diagnosis. In addition, we developed a short peptide ligand (NARKFYKG, NAR) to avoid the occupation of antigen binding sites by specifically connecting to Fc fragments in antibodies. Thus, the binding efficiency of antibodies and the activity of biosensors were improved due to the introduction of NAR.

Electrochemical stripping chemiluminescence coupled with recycling amplification strategy for sensitive detection of carcinoembryonic antigen

As a new generation of electrochemiluminescence (ECL) technology, the electrochemical stripping chemiluminescence (ESCL), which combines the advantages of chemiluminescence and stripping voltammetry, has attracted increasing attention in the biosensor field. Here, Ag nanoclusters (NCs) were prepared using DNA double strands as a template and explored to construct an ESCL aptamer sensor (aptasensor) for the detection of a carcinoembryonic antigen (CEA). During the detection process, Ag NCs and the Ag+ cations stripped out from Ag NCs were found to respectively catalyze the electrochemical reduction and oxidation of H2O2, accelerating the decomposition of H2O2 to generate reactive oxygen species (ROSs) and thus effectively enhancing the ECL intensity of luminol. Coupled with the exonuclease I-assisted recycling amplification technology, the developed ESCL aptasensor enabled the sensitive detection of CEA, exhibiting a broad linear response from 100 ag/mL to 10 ng/mL with a low detection limit of 38.86 ag/mL (S/N = 3). In addition, the aptasensor showed good performance in the determination of CEA in human serum with a relative standard deviation (RSD) below 5 %. This work provides an effective method for constructing simple, fast, and sensitive biosensors.

High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease.

Objective: Large-scale screening of the general population for islet autoantibodies (IAbs) to detect type 1 diabetes (T1D) has started worldwide. The standard screening method of separate radio-binding assay (RBA) for each IAb is an inefficient bottleneck. Furthermore, most positive results by RBA in screening of general population individuals without a clinical diagnosis of T1D are low-affinity and not predictive of future diabetes. Research Design and Methods: We have developed and validated a novel 6-Plex assay based on electrochemiluminescence (ECL) technology that combines in a single well high-affinity IAbs (to insulin, GAD, IA-2, and ZnT8), transglutaminase autoantibodies for celiac disease, and severe acute respiratory syndrome coronavirus 2 antibodies. The Autoimmunity Screening for Kids (ASK) provided 880 serum samples, from 828 children aged 1-17 years without diabetes who were previously tested for IAbs using single ECL assays and RBA assays. Results: Levels of all six antibodies in the 6-Plex ECL assay correlated well with respective single ECL assay levels. Similar to single ECL assays, the 6-Plex ECL assay positivity was congruent with the RBA in 95% (35/37) of children who later developed T1D and in 88% (105/119) high-risk children with multiple IAbs. In contrast, only 56% (86/154, P < 0.0001) of children with persistent single IAb by RBA were found to be positive by 6-Plex ECL assay. Of 555 samples negative for all IAbs by RBA, few (0.2%-0.5%) were positive at low levels in the 6-Plex ECL assay. Conclusions: The study demonstrated that the 6-Plex ECL assay compares favorably to the standard RBAs in terms of disease specificity for general population screening in children. The 6-Plex ECL assay was therefore adopted as the primary screening tool in the general population screening ASK program with advantages of high efficiency, low cost, and low serum volume.

A Bioinspired Photocatalysis and Electrochemiluminescence Scaffold for Simultaneous Degradation and In Situ Evaluation

AbstractNanostructured scaffolds that optimize self‐responsive ability, visible light harvesting, redox center distribution, and species shuttling porosity have been mimicked much less often, especially using organic crystalline substances. Inspired by a natural photosynthetic thylakoid membrane, a synthetic strategy with general applicability to construct a hollow organic crystalline nanosphere by orderly hybridizing imine‐linked covalent organic frameworks (COFs) with polymeric hollow g‐C3N4 nanosphere is proposed. As a proof‐of‐concept application, in a homemade microreaction cell, these hollow organic nanospheres are shown to function as robust scaffolds, heterojunction shells, and light‐harvesting antennas, enabling excellent visible‐light‐driven photocatalysis for the almost complete degradation of tetracycline, a gravely residual antibiotic worldwide. Significantly, a new electrochemiluminescence (ECL) technology derived from biomimetic self‐responsiveness is developed for in situ evaluation of the photodegradation process, accessing kinetics and other relevant parameters at an extremely low‐abundance target, which remains challenging to date, albeit highly desirable. This work provides a general synthetic strategy for obtaining COFs‐derived hollow crystalline organic nanospheres for promising photocatalysis applications and offers a new perspective on the development of ECL technology for simultaneous analysis and treatment of actual sewage.

Graphdiyne: A New Carbon Allotrope for Electrochemiluminescence

AbstractGraphdiyne (GDY), a well‐known 2D carbon allotrope, demonstrates increasing fantastic performance in various fields owing to its outstanding electronic properties. Owing to its unique properties, electrochemiluminescence (ECL) technology is one powerful tool for understanding fundamental questions and for ultrasensitive sensing and imaging. Here, we firstly find that GDY without any functionalization or treatment shows a strong ECL emission with potassium persulfate (K2S2O8) as coreactant, which is totally different with other carbon allotropes. Mechanistic study indicates that the ECL emission of GDY is generated by the surface state transition. Interestingly, ECL is generated at 705 nm in the near infrared region with an ECL efficiency of 424 % compared to that of Ru(bpy)3Cl2/K2S2O8. The study demonstrates a new character of GDY in ECL investigation and sets the stage for the development of GDY for emerging applications, including imaging and light‐emitting devices.

Graphdiyne: A New Carbon Allotrope for Electrochemiluminescence.

Graphdiyne (GDY), a well-known 2D carbon allotrope, demonstrates increasing fantastic performance in various fields owing to its outstanding electronic properties. Owing to its unique properties, electrochemiluminescence (ECL) technology is one powerful tool for understanding fundamental questions and for ultrasensitive sensing and imaging. Here, we firstly find that GDY without any functionalization or treatment shows a strong ECL emission with potassium persulfate (K2 S2 O8 ) as coreactant, which is totally different with other carbon allotropes. Mechanistic study indicates that the ECL emission of GDY is generated by the surface state transition. Interestingly, ECL is generated at 705 nm in the near infrared region with an ECL efficiency of 424 % compared to that of Ru(bpy)3 Cl2 /K2 S2 O8 . The study demonstrates a new character of GDY in ECL investigation and sets the stage for the development of GDY for emerging applications, including imaging and light-emitting devices.

Advances in Electrochemiluminescence Biosensors Based on DNA Walkers.

Mediated by Watson-Crick base-pairing principle, DNA can be used to construct multi-functional molecular machines, such as DNA walkers, tweezers, logic gates and motors. It is noteworthy that DNA walkers with the advantages of programmability and diverse structures within the micro-nano scale have attracted intense attention in the field of biosensing, bioimaging, drug delivery, and genetic diagnosis. DNA walkers are comprised of driving power, walking strands and the tracks. The driving power acts as an external stimulus and the tracks as a platform for the walking strands to move autonomously. Under the specific external stimulus as driving power, such as strand displacement strategies, enzymatic reactions and environmental condition stimulus, DNA walkers could realize the generation and amplification of signals. Electrochemiluminescence (ECL) biosensors, combining ECL technology and bio-identification strategies, exhibit the virtue of high sensitivity, wide linear response range and low background interference. Recently, the construction of DNA walker-based ECL biosensors can amplify the targets and signals via multiple identification and recycles, achieving ultrasensitive detection for diverse targets. Herein, this review systematically summarizes the construction of different types of DNA walkers and their applications in ECL biosensors. Ultimately, this review summarizes and discusses the prospects for DNA walkers.

Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.

Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19) presents occasionally with an aberrant autoinflammatory response, including the presence of elevated circulating autoantibodies in some individuals. Whether the development of autoantibodies against self-antigens affects COVID-19 outcomes remains unclear. To better understand the prognostic role of autoantibodies in COVID-19, we quantified autoantibodies against 23 markers that are used for diagnosis of autoimmune disease. To this end, we used serum samples from patients with severe [intensive care unit (ICU)] and moderate (ward) COVID-19, across two to six consecutive time points, and compared autoantibody levels to uninfected healthy and ICU controls. Acute and post-acute serum (from 1 to 26 ICU days) was collected from 18 ICU COVID-19-positive patients at three to six time points; 18 ICU COVID-19-negative patients (sampled on ICU day 1 and 3); 21 ward COVID-19-positive patients (sampled on hospital day 1 and 3); and from 59 healthy uninfected controls deriving from two cohorts. Levels of IgG autoantibodies against 23 autoantigens, commonly used for autoimmune disease diagnosis, were measured in serum samples using MSD® U-PLEX electrochemiluminescence technology (MSD division Meso Scale Discovery®), and results were compared between groups. There were no significant elevations of autoantibodies for any of the markers tested in patients with severe COVID-19. Sample collections at longer time points should be considered in future studies, for assessing the possible development of autoantibody responses following infection with SARS-CoV-2.

Electrochemiluminescence sensors and forensic investigations: a viable technique for drug detection?

Abstract Novel psychoactive substances (NPS) are today considered one of the major ticking public health time bombs in regard to drug abuse. The inability to identify these substances with current screening methods, sees their distribution remain uninterrupted and contributes to the high death rates amongst users. To tackle this problem, it is vital that new robust screening methods are developed, addressing the limitation of those currently in place, namely colour subjectivity and lack of compatibility with the complex matrices these substances may be found within. To this avail, electrochemical methods have been assessed. These low cost and extremely portable sensors have been successfully applied for the direct detection of a broad range of compounds of interest in a range of matrices including, herbal material, commercial drinks and biological fluids (serum, saliva, sweat and urine). With their high versatility, gifted through a significant degree of flexibility in regard to electrode material a range of sensors have to date been reported. In this review the various electrochemical sensors developed to date for NPS detection will be compared and contrasted, with a special focus upon those utilising electrochemiluminescence (ECL) technology.

COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency

BackgroundThe coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six weeks of the second dose of the COVID-19 vaccine.MethodsParticipants of the study were healthcare workers of a tertiary care cardiac center including doctors, nursing staff, paramedics, and office staff. All participants were fully vaccinated with recommended double dose of available vaccine at least six weeks before the study. A blood sample of five milliliters was collected from all the participants by a trained phlebotomist at a local laboratory, and COVID-19 antibodies titer level was assessed using Food and Drug Administration (FDA) approved kit with a standard range of 1.0. This qualitative assay detects IgG and IgM as total antibodies targeted against nucleocapsid antigen performed on a fully automated cobas® 6000 analyzer (F. Hoffmann-La Roche Ltd, Basel, Switzerland) using electrochemiluminescence technology. COVID-19 antibodies titer levels were categorized as ≤100, 101-250, and >250.ResultsA total of 151 healthcare workers were included, of which 70.2% (106) were male. The history of COVID-19 infection before vaccination was found in 41.1% (62). The mean duration since the last dose of the vaccine was 89.6±40.07 days. In total 71.5% (108) had antibodies titer level of >250, which were mostly found in participants of younger age and who had previous COVID-19 infection. However, antibodies titer level of >250 were observed in 84% (21/25) at 61 to 90 days of vaccination, which declined to 80% (20/25) after 91 to 120 days and to 57.1% (32/56) after >120 days of vaccination.ConclusionsGood antibodies titer levels were observed in vaccinated healthcare workers, especially in those who were younger and had previous COVID-19 infection.

Recent advances in II-VI quantum dots based-signal strategy of electrochemiluminescence sensor

Electrochemiluminescence technology is widely used in the highly sensitive detection of environmental pollutants, biologically active molecules, nucleic acids and tumor markers based on its high sensitivity, good selectivity and excellent stability. Quantum dots have become an ideal electrochemiluminescence luminescent material due to their amazing optical properties, good water solubility and good electrochemiluminescence monochromaticity. The further research on signal transduction strategies of electrochemiluminescence sensors based on II-VI quantum dots on will contribute to the construction of advanced sensors. Therefore, this review summarizes the electrochemiluminescence mechanism and electrochemiluminescence sensing signal transduction strategies based on II-VI quantum dots. Three electrochemiluminescence sensing mode (signal-off transduction strategy, signal-on transduction strategy and ratiometric transduction strategy) are introduced emphatically. Finally, the challenges and future development directions faced by II-VI quantum dots based- electrochemiluminescence sensors are discussed according to the development status of the II-VI quantum dot electrochemiluminescence sensing signal transduction strategy and its application in electrochemiluminescence sensors.

Прогностическая значимость соотношения ангиогенных факторов sFlt-1/PlGF в качестве маркера преэклампсии у беременных двойней

Objective. To develop reference values for the sFlt-1/PlGF ratio in twin pregnancy and to establish its significance as a marker for pre-eclampsia (PE). Patients and methods. Sixty-two women with a dichorionic diamniotic (DCDA) twin pregnancy were examined: 44 women without PE and 18 women with PE. Levels of sFlt-1 and PlGF and their ratio were studied at 15,0–19,6; 20–23,6; 24–28,6; 29–33,6; 34–36,6 weeks’ gestation. Serum sFlt-1 and PlGF concentrations were measured by the cobas e 411 immunochemical analyzer (Roche Diagnostics GmbH, Germany) that uses electrochemiluminescence technology. Results. In uncomplicated twin pregnancy, serum concentrations of sFlt-1 and PlGF and their ratio were significantly elevated, which were higher than those in singleton pregnancy (SP); the sFlt-1/PlGF ratio was 13.7 by the end of the 37th week of pregnancy versus 9.0 in SP. In patients with PE, the median sFlt-1/PlGF ratio was 66.56, which was 4.8 times higher than in uncomplicated twin pregnancy. Using ROC analysis, threshold values for the sFlt-1/PlGF ratio were determined, allowing us with a high level of significance to exclude (&lt;20.06; 100% sensitivity and 90% specificity) and to diagnose PE (&gt;50.07; 60% sensitivity and 100% specificity). Conclusion. The developed accurate reference values for the sFlt-1/PIGF ratio in twin pregnancy enable early diagnosis of PE and prediction of the course of the disease. Key words: angiogenic factors, twins, twin pregnancy, pre-eclampsia

Preparation of a disposable electrochemiluminescence sensor chip based on an MXene-loaded ruthenium luminescent agent and its application in the detection of carcinoembryonic antigens.

Carcinoembryonic antigen (CEA) is an important cancer marker that plays a significant role in achieving low-cost, rapid and highly sensitive clinical detection. In this work, we developed a disposable electrochemiluminescence (ECL) sensor chip based on a screen-printed electrode (SPE) for detecting CEA via ECL technology. An amino-modified Ti3C2 MXene was used as a carrier to successfully prepare a highly efficient ECL probe AuNPs-Ru-Arg@NH2-Ti3C2-MXene by loading with AuNPs-Arg through covalent links and modifying with a ruthenium complex. Upon the addition of CEA, the ECL signal decreased significantly with the increase of CEA, due to the formation of immune complexes at the interface of the electrode. The sensing chip was used to detect CEA in an aqueous solution and found to have a detection limit of 1.5 pg mL-1. The chip was used to determine CEA in the serum of healthy humans and cancer patients, and the results were consistent with those obtained using ELISA. The disposable ECL sensor chip has many advantages including convenience, rapid detection, low cost and easy mass production; thus it has great application potential in clinical cancer diagnosis.

Co-Quenching Effect between Lanthanum Metal-Organic Frameworks Luminophore and Crystal Violet for Enhanced Electrochemiluminescence Gene Detection.

Exploring new electrochemiluminescence (ECL) luminophores to construct high-efficiency sensing systems is always a hot direction for developing ECL sensors. Compared with other luminophores, metal-organic frameworks (MOFs) exhibit high mass transfer ability for accelerating the reactivity in its pore channels, which is conducive to improving the performance of ECL sensors. In this work, La3+ -BTC MOFs (LaMOFs) are prepared as the highly active reactor and novel ECL luminophore. On this basis, a novel co-quenching effect mechanism is proposed based on double-stranded DNA (dsDNA) triggered cooperation between LaMOFs and crystal violet (CV) molecules. Under the confined pore channels of LaMOFs, CV can play an important role as the photon-acceptor due to the matched absorption spectrum with the ECL spectrum of LaMOFs, and the electron-acceptor on account of its lowest unoccupied molecular orbital level. Based on the proposed co-quenching effect mechanism, a constructed ECL gene sensor shows good assay performance toward p53 gene in the detection range of 1 pm to 100nm with a detection limit of 0.33 pm. The co-quenching effect integrating LaMOFs with CV is expected to be a versatile approach in the construction of ECL gene sensor, which has good prospect in expanding the application range of ECL technology.

Plasma interleukin-6 is a potential predictive biomarker for postoperative delirium among acute type a aortic dissection patients treated with open surgical repair

ObjectivesThe relationship between inflammatory cytokines and postoperative delirium (POD) remains to be further investigated, especially in patients undergoing acute type A aortic dissection (AAD). Interleukin-6 (IL-6) is involved in the inflammatory process and has recently been identified as a biomarker of cerebral dysfunction. We explored the hypothesis that IL-6 was one of the critical causes of POD after surgical repair of AAD.MethodsPlasma IL-6 was measured using electrochemiluminescence technology in patients preoperatively and 24 h, 48 h, and 72 h after surgical repair of acute type A aortic dissection. After the first three postoperative days, delirium was evaluated twice daily using the Confusion Assessment Method. ROC curves were used to evaluate the ability of IL-6 measurements to distinguish POD.ResultsThe incidence of POD was 14.03% (31 of 221 patients). The patients in the POD group were significantly older than the patients in the non-POD group (56.48 ± 11.68 years vs 52.22 ± 10.50 years, P = 0.040). Plasma IL-6 concentrations were significantly higher in the POD group than in the non-POD group at three time points: preoperatively, after 24 h, and after 48 h. The AUC values corresponding to IL-6 preoperatively and 24 h after surgery were 0.73 and 0.72, respectively.ConclusionsCerebral dysfunction after the surgical repair of AAD shows elevated stress levels and inflammatory responses. Plasma IL-6 is a potential biomarker to predict the onset of POD in acute type A aortic dissection patients following surgical repair.

Development and validation of an immunoassay for quantification of NCAM-1 in human plasma

BackgroundNeural Cell Adhesion Molecule 1 (NCAM-1), a multifunctional member of the immunoglobulin superfamily, is expressed on the surface of neurons, glia, skeletal muscle, and natural killer cells. NCAM-1 has been implicated as having a role in cell-cell adhesion, involved in development of the nervous system, and for cells involved in the expansion of T cells and dendritic cells which play an important role in immune surveillance. Sensitive and specific methods to quantify non-surface bound NCAM-1 are not available. MethodA sandwich ligand binding assay was developed for quantification of NCAM-1 in plasma and validated using an electro-chemiluminescent (ECL) technology. ResultsThe data presented here demonstrated that the validated method met all prespecified criteria for precision, linearity, and accuracy in the range of 62.5 ng/mL to 4000.0 ng/mL, the range believed to be most relevant for plasma. The bioanalytical validation of the assay established the inter-assay coefficient of variation <8 % for calibration points, <2 % for high quality control (HQC), <8 % for medium quality control (MQC) and <19 % for low quality control (LQC) samples. Purified NCAM-1 spike-recovery experiment in plasma was used to determine assay accuracy; nominal concentrations (%) of NCAM-1 ranged from 91 % to 112 % for high and low spike level, respectively. Assay performance was subsequently evaluated for parallelism, selectivity, interference, and stability. ConclusionNCAM-1 assay has been developed and validated in human plasma and met all assay validation parameters pre-determined during development. Clinical testing of human plasma samples indicated that NCAM-1 does not seem to be influenced by age and was slightly influenced by gender. NCAM-1 assay has potential to be used as a biomarker assay once the assay is subjected to appropriate clinical assessment and diagnostic thresholds are established.

Correlation of sPD1 with Procalcitonin and C-Reactive Protein Levels in Patients with Sepsis.

Objective Sepsis results from dysregulated host responses to infection, and it is a major cause of mortality in the world. Co-inhibitory molecules, such as PD-1, play a critical role in this process. Considering the lack of information on the relation between sPD1 and sepsis, the present study aimed to examine the sPD1 level in septic patients and evaluate its correlation with procalcitonin (PCT) and C-reactive protein (CRP) levels. Materials and Methods This descriptive cross-sectional study consisted of three groups, including septic patients (n=15), suspected of sepsis (n=15), and healthy subjects (n=15). White blood cells (WBCs) and platelet (PLT) counts are evaluated. The serum levels of CRP, PCT, and sPD1 were measured by immunoturbidimetric assay, electro- chemiluminescence technology, and the enzyme-linked immunosorbent assay (ELISA), respectively. Results Our study indicated that there was a significant difference in WBC and PLT counts between the septic group compared to suspected and control groups (P<0.001, P<0.01, respectively). The CRP level was significantly higher in septic compared to suspected and control groups (P<0.001). There was also a significant difference between the PCT level in septic and suspected groups in comparison with the controls (P<0.001, P<0.01). The sPD1 level was significantly higher in septic patients compared to suspected and control groups (P<0.001). In septic patients, sPD1 levels were correlated positively with the CRP and PCT levels. ConclusionOverall, sPD1 correlation with inflammatory markers, might propose it as a potential biomarker to sepsis diagnosis. However, the clinical application of serum sPD-1 testing in patients with sepsis requires further investigation.

Testosterone or Dehydroepiandrosterone Sulfate as a Biomarker for Hirsutism in Women with Polycystic Ovary Syndrome

Background:Hirsutism is a distressing medical problem for women. Most of hirsutism in women is associated with excess androgen, and most cases have PCOS as an underlying cause.Which androgen to be used to evaluate clinical or biochemical hyperandrogenism in women with PCOS is still debated.There are a small number of studies that evaluated androgens in women with PCOS having hirsutism with conflicting results. The Objective of this study was to determine which androgen predict hirsutism in women with polycystic ovary syndrome (PCOS). Patients and Methods:A case-control study was done in Faiha Specialized Diabetes, Endocrine, and Metabolism Center (FDEMC), Basrah, Iraq. A total of 130 women with PCOS (based on Rotterdam criteria) and 70 healthy controls of comparable age (16-40 years) were investigated for androgens (total testosterone, free testosterone, DHEA-S) using Electrochemiluminescence technology assay; excess hair was examined according to the modified Ferriman-Gallwey (mFG) score and a cut-off value of 8 defined hirsutism. Results: In the three groups of women, the first (n=100) included PCOS with hirsutism, the second (n=30) PCOS without hirsutism, and the third (n=70) women without PCOS or hirsutism as healthy control, hirsutism was seen in about 77 % of PCOS women mostly of moderate severity; High TT, FT, DHEA-S, and overall androgens were seen in 69%, 76%, 37%, and 99% respectively of our PCOS women with hirsutism. No correlation was found between TT, FT, and DHEA-S and the mFG score. Conclusions: This study provides evidence that presence of hirsutism in women with PCOS was associated with a higher level of biochemical hyperandrogenism than seen in PCOS without hirsutism; however, there was no correlation between the studied androgens and mFG score.